BioVectra

BIOVECTRA is a North American contract drug manufacturing organization (CDMO) that specializes in the production of high-quality active pharmaceutical ingredients (APIs) and intermediates, including biologics, synthetic small molecules, plasmid DNA (pDNA), and messenger RNA (mRNA). The company also offers robust microbial fermentation capabilities, supporting products from pilot to commercial scale. With over 50 years of experience, BIOVECTRA serves pharmaceutical companies by optimizing and perfecting innovative technologies and drug substance development approaches. The company operates in the pharmaceutical manufacturing market and generates revenue through contract manufacturing services, providing solutions from research and testing to full-scale manufacturing. BIOVECTRA's business model focuses on delivering flexible and innovative manufacturing solutions, ensuring high-quality production standards. The company is committed to a patient-first, risk-based approach to process development and manufacturing.

Keywords: CDMO, APIs, biologics, microbial fermentation, pharmaceutical manufacturing, pDNA, mRNA, drug development, North America, innovative technologies.